Ekso Bionics EKSO Stock
Ekso Bionics Price Chart
Ekso Bionics EKSO Financial and Trading Overview
| Ekso Bionics stock price | 0.44 USD |
| Previous Close | 1.34 USD |
| Open | 1.38 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 800 |
| Day's Range | 1.34 - 1.41 USD |
| 52 Week Range | 1.03 - 2.51 USD |
| Volume | 13.31K USD |
| Avg. Volume | 23.95K USD |
| Market Cap | 18.36M USD |
| Beta (5Y Monthly) | 1.816901 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.56 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
EKSO Valuation Measures
| Enterprise Value | 9.59M USD |
| Trailing P/E | N/A |
| Forward P/E | -1.8133334 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.2693678 |
| Price/Book (mrq) | 0.8526646 |
| Enterprise Value/Revenue | 0.663 |
| Enterprise Value/EBITDA | -0.653 |
Trading Information
Ekso Bionics Stock Price History
| Beta (5Y Monthly) | 1.816901 |
| 52-Week Change | -24.44% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.51 USD |
| 52 Week Low | 1.03 USD |
| 50-Day Moving Average | 1.51 USD |
| 200-Day Moving Average | 1.54 USD |
EKSO Share Statistics
| Avg. Volume (3 month) | 23.95K USD |
| Avg. Daily Volume (10-Days) | 20.27K USD |
| Shares Outstanding | 13.5M |
| Float | 12.06M |
| Short Ratio | 1.58 |
| % Held by Insiders | 8.20% |
| % Held by Institutions | 14.76% |
| Shares Short | 34.99K |
| Short % of Float | 0.27% |
| Short % of Shares Outstanding | 0.26% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -102.64% |
| Operating Margin (ttm) | -108.98% |
| Gross Margin | 48.41% |
| EBITDA Margin | -101.59% |
Management Effectiveness
| Return on Assets (ttm) | -24.22% |
| Return on Equity (ttm) | -54.22% |
Income Statement
| Revenue (ttm) | 14.47M USD |
| Revenue Per Share (ttm) | 1.1 USD |
| Quarterly Revenue Growth (yoy) | 60.60% |
| Gross Profit (ttm) | N/A |
| EBITDA | -14697000 USD |
| Net Income Avi to Common (ttm) | -14849000 USD |
| Diluted EPS (ttm) | -1.12 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 16.28M USD |
| Total Cash Per Share (mrq) | 1.21 USD |
| Total Debt (mrq) | 7.51M USD |
| Total Debt/Equity (mrq) | 35.26 USD |
| Current Ratio (mrq) | 2.894 |
| Book Value Per Share (mrq) | 1.595 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -14696000 USD |
| Levered Free Cash Flow (ttm) | -10175375 USD |
Profile of Ekso Bionics
| Country | United States |
| State | CA |
| City | San Rafael |
| Address | 101 Glacier Point |
| ZIP | 94901 |
| Phone | 510 984 1761 |
| Website | https://www.eksobionics.com |
| Industry | Medical Instruments & Supplies |
| Sector(s) | Healthcare |
| Full Time Employees | 72 |
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Europe, the Middle east, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company also provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therap, an adjustable and lower-limb powered exoskeleton; and Ekso Indego Personal, a powered lower limb orthosis. It has a license agreement with Lockheed Martin Corporation. The company was incorporated in 2005 and is headquartered in San Rafael, California.
Q&A For Ekso Bionics Stock
What is a current EKSO stock price?
Ekso Bionics EKSO stock price today per share is 0.44 USD.
How to purchase Ekso Bionics stock?
You can buy EKSO shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ekso Bionics?
The stock symbol or ticker of Ekso Bionics is EKSO.
Which industry does the Ekso Bionics company belong to?
The Ekso Bionics industry is Medical Instruments & Supplies.
How many shares does Ekso Bionics have in circulation?
The max supply of Ekso Bionics shares is 28.2M.
What is Ekso Bionics Price to Earnings Ratio (PE Ratio)?
Ekso Bionics PE Ratio is now.
What was Ekso Bionics earnings per share over the trailing 12 months (TTM)?
Ekso Bionics EPS is -0.56 USD over the trailing 12 months.
Which sector does the Ekso Bionics company belong to?
The Ekso Bionics sector is Healthcare.
Ekso Bionics EKSO included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Capital Market Composite RCMP | 102.15 USD — |
-0.54
|
— — | 101.35 USD — | 102.39 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}